A pan-haematologic cancer approach, involving analysis of data from 256 patients across 5 cancer types and 13 clinical trials, revealed predictive biomarkers for understanding the response or non-response of patients to CAR-T therapy.
- Gregory M. Chen
- Ankita Jain
- Joseph A. Fraietta